Leucadia Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5902 Speyside Rd, Riverside, California,...Website
www.leucadiatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Leucadia Therapeutics
Leucadia Therapeutics is dedicated to erasing Alzheimer's Disease through innovative treatments. Their primary product, Arethusta, is a first-in-class outpatient treatment aimed at reversing mild cognitive impairment and ultimately curing Alzheimer's. The company is currently conducting a clinical study, Project Cribrose, to refine diagnostic tools for assessing Alzheimer's risk. Leucadia Therapeutics is focused on providing solutions for patients and families affected by Alzheimer's Disease.Explore more
Leucadia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leucadia Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Leucadia Therapeutics is spiking on competitors!
Earning: See what the market has to say on Leucadia Therapeutics recently announced quarterly report
Product Launch: Get notified when Leucadia Therapeutics launches new products
Click to see if Leucadia Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Leucadia Therapeutics has new funding data
Leucadia Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Leucadia Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Leucadia Therapeutics
Recommended Actions
Reach out to Masked Content who joined Leucadia Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Leucadia Therapeutics
Compare insights from companies similar to Leucadia Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Leucadia Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Leucadia Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Leucadia Therapeutics.
Leucadia Therapeutics Tech Stack
A closer look at the technologies used by Leucadia Therapeutics
Leucadia Therapeutics News & Media
Former Global Fund Manager Joins Leucadia Therapeutics as Company's First CFO
Edward Shadek, Jr., former deputy chief of Investments at Putnam, brings wealth of financial acumen as company prepares for clinical trials SAN DIEGO, Aug. 15, 2022 /PRNewswire/ -- Leucadia Therapeutics, a company working to cure Alzheimer's disease with a medical device implanted by...Alzheimer's Disease Researchers Release Free Memory Tracking App
SAN DIEGO, July 9, 2021 /PRNewswire/ -- Today, Leucadia Therapeutics Inc, a California HealthTech Company, is launching 8 Apps that help exercise memory and cognition, including a personalized memory tracker called ProCogny (procogny.com). ProCogny allows users to play memory-intensive...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Leucadia Therapeutics
Sign Up For FreeTo access detailed company insights
Leucadia Therapeutics is dedicated to erasing Alzheimer's Disease through innovative treatments. Their primary product, Arethusta, is a first-in-class outpatient treatment aimed at reversing mild cognitive impairment and ultimately curing Alzheimer's. The company is currently conducting a clinical study, Project Cribrose, to refine diagnostic tools... Read More
